1. Home
  2. CDXC vs CAN Comparison

CDXC vs CAN Comparison

Compare CDXC & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • CAN
  • Stock Information
  • Founded
  • CDXC 1999
  • CAN 2013
  • Country
  • CDXC United States
  • CAN Singapore
  • Employees
  • CDXC N/A
  • CAN N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • CAN Semiconductors
  • Sector
  • CDXC Health Care
  • CAN Technology
  • Exchange
  • CDXC Nasdaq
  • CAN Nasdaq
  • Market Cap
  • CDXC 415.5M
  • CAN 425.9M
  • IPO Year
  • CDXC N/A
  • CAN 2019
  • Fundamental
  • Price
  • CDXC $5.48
  • CAN $2.22
  • Analyst Decision
  • CDXC Strong Buy
  • CAN Strong Buy
  • Analyst Count
  • CDXC 2
  • CAN 3
  • Target Price
  • CDXC $8.00
  • CAN $3.00
  • AVG Volume (30 Days)
  • CDXC 587.4K
  • CAN 23.9M
  • Earning Date
  • CDXC 10-31-2024
  • CAN 02-25-2025
  • Dividend Yield
  • CDXC N/A
  • CAN N/A
  • EPS Growth
  • CDXC N/A
  • CAN N/A
  • EPS
  • CDXC 0.02
  • CAN N/A
  • Revenue
  • CDXC $91,668,000.00
  • CAN $229,630,000.00
  • Revenue This Year
  • CDXC $18.64
  • CAN $24.51
  • Revenue Next Year
  • CDXC $20.72
  • CAN $84.90
  • P/E Ratio
  • CDXC $274.95
  • CAN N/A
  • Revenue Growth
  • CDXC 9.95
  • CAN N/A
  • 52 Week Low
  • CDXC $1.36
  • CAN $0.72
  • 52 Week High
  • CDXC $7.97
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 39.30
  • CAN 49.58
  • Support Level
  • CDXC $5.26
  • CAN $2.02
  • Resistance Level
  • CDXC $5.56
  • CAN $2.39
  • Average True Range (ATR)
  • CDXC 0.29
  • CAN 0.31
  • MACD
  • CDXC -0.09
  • CAN -0.09
  • Stochastic Oscillator
  • CDXC 18.88
  • CAN 16.67

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

Share on Social Networks: